Our CEO Dr. Ryu Ogawa and CSO Dr. Satoshi Tamaki were interviewed by Pharma Boardroom about MOLCURE’s impact in the drug discovery process.

Pharma boardroomに弊社の小川（CEO）と玉木（CSO）のインタビューが掲載されました。

Link to article can be found here.